Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.
暂无分享,去创建一个
Dan Theodorescu | Mark Smolkin | H. Frierson | G. Hampton | D. Theodorescu | W. El-Rifai | Steven C. Smith | M. Smolkin | Wael El-Rifai | B. Nicholson | M. Nitz | Henry F Frierson | Steven Christopher Smith | Brian Nicholson | Matthew Nitz | Garret Hampton | Matthew D. Nitz
[1] P. Nowell,et al. Differential growth of metastatic tumors in liver and lung; experiments with rabbit V2 carcinoma. , 1952, Cancer research.
[2] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[3] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[4] H. Frierson,et al. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.
[5] D. Theodorescu,et al. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer , 2000, Genes, chromosomes & cancer.
[6] K. Arden,et al. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. , 2002, Cancer research.
[7] C. Moskaluk,et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. , 2002, Cancer research.
[8] L. Qin. Chromosomal aberrations related to metastasis of human solid tumors. , 2002, World journal of gastroenterology.
[9] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[11] C. Moskaluk,et al. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity , 2004, Oncogene.
[12] H. Frierson,et al. Profiling the Evolution of Human Metastatic Bladder Cancer , 2004, Cancer Research.
[13] Chi-Hung Lin,et al. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases—An analysis by comparative genomic hybridization , 2005, Genes, chromosomes & cancer.
[14] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[15] C. Horak,et al. Metastasis gets site specific. , 2005, Cancer cell.
[16] N. Kinukawa,et al. Overexpression of laminin-5 γ2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2 , 2005 .
[17] W. Gerald,et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.
[18] Xue-Ru Wu. Urothelial tumorigenesis: a tale of divergent pathways , 2005, Nature Reviews Cancer.
[19] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[20] V. Quaranta,et al. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. , 2005, The Journal of biological chemistry.
[21] I. Petersen,et al. Chromosomal Alterations in Lung Metastases of Colorectal Carcinomas: Associations with Tissue Specific Tumor Dissemination , 2005, Clinical & Experimental Metastasis.
[22] H. Frierson,et al. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. , 2005, Cancer research.
[23] F. Algaba. Lymphovascular invasion as a prognostic tool for advanced bladder cancer , 2006, Current opinion in urology.
[24] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[25] H. Frierson,et al. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. , 2006, Cancer research.
[26] H. Frierson,et al. A novel method for gene expression mapping of metastatic competence in human bladder cancer. , 2006, Neoplasia.
[27] D. Theodorescu,et al. Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer , 2007, Clinical Cancer Research.
[28] O. Gires,et al. EpCAM (CD326) finding its role in cancer , 2007, British Journal of Cancer.
[29] A. Tzankov,et al. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder , 2007, Journal of Clinical Pathology.
[30] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[31] C. Christophi,et al. Liver Regeneration and Tumor Stimulation—A Review of Cytokine and Angiogenic Factors , 2008, Journal of Gastrointestinal Surgery.
[32] Kedar S Vaidya,et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. , 2007, Journal of the National Cancer Institute.
[33] O. Gires,et al. EpCAM (CD326) finding its role in cancer , 2007, British Journal of Cancer.
[34] C. Christophi,et al. Liver regeneration stimulates tumor metastases. , 2007, The Journal of surgical research.
[35] P. Steeg,et al. Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.
[36] R. Weinberg. Leaving home early: reexamination of the canonical models of tumor progression. , 2008, Cancer cell.